/Companies

APT

Naperville, US · 1 known investors

Find your way into APT

Sign up to see every warm intro you have to APT

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the APT team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

APT Therapeutics develops therapeutics based on human apyrase to treat thrombotic and cardiovascular conditions such as heart attack, stroke, acute lung injury, and pulmonary arterial hypertension. Its approach targets platelet aggregation, a driver of thrombotic diseases.

Investors · 1

Frequently asked questions

What does APT do?
APT Therapeutics develops therapeutics based on human apyrase to treat thrombotic and cardiovascular conditions such as heart attack, stroke, acute lung injury, and pulmonary arterial hypertension. Its approach targets platelet aggregation, a driver of thrombotic diseases.
Who are APT's investors?
APT's investors include BioGenerator Ventures.
Where is APT headquartered?
APT is headquartered in Naperville, US.